Showing 1,121 - 1,140 results of 2,245 for search '"Рациональная фармакотерапия в кардиологии"', query time: 0.05s Refine Results
  1. 1121
    Coagulation Disorders in Infective Endocarditis: Role of Pathogens, Biomarkers, Antithrombotic Therapy (Systematic Review)

    Coagulation Disorders in Infective Endocarditis: Role of Pathogens, Biomarkers, Antithrombotic Therapy (Systematic Review) by A. S. Pisaryuk, V. A. Zamarashkina, N. B. Safarova, N. M. Povalyaev, E. O. Kotova, U. I. Babukhina, E. M. Koltsova, Zh. D. Kobalava

    Published 2022-07-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 1122
    CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME

    CORRELATION OF INFLAMMATION BIOMARKERS WITH THE TRADITIONAL RISK FACTORS IN PATIENTS WITH ACUTE CORONARY SYNDROME by I. S. Skopec, N. N. Vezikova, I. M. Marusenko, O. Yu. Barysheva, A. V. Malafeev, A. N. Malygin

    Published 2016-05-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 1123
    EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY

    EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY by A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko

    Published 2015-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 1124
    Fighting with obesity: the "gold standard" and new horizons

    Fighting with obesity: the "gold standard" and new horizons by O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov

    Published 2016-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 1125
    Which сlinical, laboratory, and instrumental factors are associated with the development of the no-reflow phenomenon in patients with acute coronary syndrome?

    Which сlinical, laboratory, and instrumental factors are associated with the development of the no-reflow phenomenon in patients with acute coronary syndrome? by E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, A. O. Chernikov, M. S. Zhdanova, E. V. Ploshchenkov

    Published 2025-08-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 1126
    COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015

    COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 by O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman

    Published 2018-03-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 1127
    ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION

    ANGIOTENSIN CONVERTING ENZYME INHIBITORS: DECREASE IN HEART REMODELING AND IMPROVEMENT IN FUNCTION OF ENDOTHELIUM IN PATIENTS WITH ARTERIAL HYPERTENSION by K. Yu. Nikolaev, G. I. Lifshits, A. A. Nikolaeva, I. M. Gicheva

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 1128
    Ventricular Tachycardia Induced by Exercise Test as a Predictor of Coronary Artery Disease Development

    Ventricular Tachycardia Induced by Exercise Test as a Predictor of Coronary Artery Disease Development by A. A. Tatarinova, E. A. Ryngach, T. V. Treshkur, D. V. Ryzhkova, O. N. Zhdanova, D. V. Svalov

    Published 2019-05-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 1129
    Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017

    Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Ins... by O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov

    Published 2019-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 1130
    Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients?

    Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? by N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva

    Published 2024-10-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 1131
    ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE

    ENDOTHELIAL DYSFUNCTIONS AND THEIR CORRECTION IN WOMEN WITH EARLY POSTMENOPAUSE by S. N. Tolstov, I. A. Salov, A. P. Rebrov

    Published 2017-05-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 1132
    Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New?

    Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? by A. N. Sumin

    Published 2022-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 1133
    RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE

    RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE by T. G. Kulikova, O. V. Stepanova, M. P. Valihov, A. Yu. Shhedrina, A. N. Samko, V. P. Masenko, S. N. Tereshhenko

    Published 2015-09-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 1134
    SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY

    SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY by E. V. Filippov, S. S. Yakushin

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 1135
    Daily breakfast: will skipping a morning meal become a new prognostic marker?

    Daily breakfast: will skipping a morning meal become a new prognostic marker? by O. B. Shvabskaia, N. S. Karamnova, O. M. Drapkina

    Published 2023-11-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 1136
    Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older

    Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older by S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, V. A. Kutsenko, Yu. A. Balanova, A. V. Kapustina, O. M. Drapkina

    Published 2025-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 1137
    INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2016

    INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2016 by article editorial

    Published 2017-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 1138
    RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY

    RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY by M. L. Maximov

    Published 2015-12-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 1139
    sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19)

    sVCAM-1 as a Marker of Endothelial Dysfunction associated with Severe Course of a Novel Coronavirus Infection (COVID-19) by V. I. Podzolkov, A. E. Pokrovskaya, D. D. Vanina, I. I. Shvedov

    Published 2023-05-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 1140
    ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES

    ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES by E. M. Khurs, A. V. Poddubnaya

    Published 2016-01-01
    “…Рациональная фармакотерапия в кардиологии…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: